SCHEMBL8188287

SCHEMBL8188287

C=C(C)OC(=O)NC(Cc1c(I)cc(Oc2cc(I)c(OCC3CO3)c(I)c2)cc1I)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 7/20 0.36
▸ MEN1 O00255 5/20 0.36
▸ KMT2A Q03164 5/20 0.36
▸ PPARG P37231 5/20 0.36
▸ THRA P10827 5/20 0.36
▸ LMNA P02545 4/20 0.36
▸ TTR P02766 2/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ PDE4D Q08499 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ NR1I2 O75469 2/20 0.36
▸ NR3C1 P04150 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ TBXA2R P21731 1/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13949740 0.86 ITGB3 (0.40) THRBMEN1KMT2APPARGTHRA
SCHEMBL12642748 0.82 THRB (0.44) THRBMEN1KMT2APPARGTHRA
SCHEMBL8189234 0.77 THRB (0.44) THRBMEN1KMT2APPARGTHRA
SCHEMBL12642753 0.74 THRB (0.61) THRBMEN1KMT2APPARGTHRA
SCHEMBL19309251 0.74 THRB (0.43) THRBMEN1KMT2APPARGTHRA
SCHEMBL12584490 0.72 THRB (0.47) THRBMEN1KMT2APPARGTHRA
SCHEMBL12584446 0.71 VDR (0.31) —
SCHEMBL14421680 0.69 THRB (0.62) THRBMEN1KMT2APPARGTHRA
SCHEMBL1526096 0.69 THRB (0.39) THRBMEN1KMT2APPARGTHRA
SCHEMBL14421812 0.69 PCNA (0.60) THRBMEN1KMT2APPARGTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110142941-A1 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof NANOPHARMACEUTICALS LLC 2011-06-16 — — US disclosed
WO-2008051291-A2 NANOPARTICLE AND POLYMER FORMULATIONS FOR THYROID HORMONE ANALOGS, ANTAGONISTS, AND FORMULATIONS THEREOF ORDWAY RESEARCH INSTITUTE (US) 2008-05-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110142941-A1 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof TSHR, THRA, TRHR THRB 4/4885MEN1 372/4885KMT2A 1916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback